{
    "2018-08-13": [
        [
            {
                "time": "2018-09-10",
                "original_text": "OPKO Health Expects Its Loss per Share to Shrink This Year",
                "features": {
                    "keywords": [
                        "OPKO",
                        "Health",
                        "Loss",
                        "Shrink",
                        "Year"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech",
                "features": {
                    "keywords": [
                        "Allakos",
                        "Sell-Side",
                        "Coverage",
                        "Biotech"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "OPKO Health’s Q3 2018 Revenue Expectations",
                "features": {
                    "keywords": [
                        "OPKO",
                        "Health",
                        "Q3",
                        "Revenue",
                        "Expectations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "How GlaxoSmithKline’s Segments Have Performed",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Segments",
                        "Performed"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Analyzing GlaxoSmithKline’s Revenue Trends",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Revenue",
                        "Trends"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Stock",
                        "Up",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Roche's Xolair Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "Roche",
                        "Xolair",
                        "Breakthrough",
                        "Therapy",
                        "Status"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Novo Nordisk: A Financial Overview after the First Half of 2018",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Financial",
                        "Overview",
                        "First",
                        "Half",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?",
                "features": {
                    "keywords": [
                        "WisdomTree",
                        "International",
                        "High",
                        "Dividend",
                        "Fund",
                        "ETF"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "The Swiss Stock Market Pared Its Losses In Late Trade",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Pared",
                        "Losses",
                        "Late",
                        "Trade"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}